Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nitin Mehrotra

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Clinical Pharmacokinetics|May 27, 2026
Vutrisiran-Mediated Knockdown of Transthyretin in Patients with ATTR AmyloidosisMarianna Fontana, Vincent Algalarrondo, Pablo Garcia-Pavia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2015
FDA approval: siltuximab for the treatment of patients with multicentric Castleman diseaseAlbert Deisseroth, Chia-Wen Ko, Lei Nie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 24, 2013
Abiraterone acetate in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer: U.S. Food and Drug Administration drug approval summaryPaul G Kluetz, Yang-Min Ning, V Ellen Maher, et al.
Journal of Clinical Pharmacology|January 23, 2020
Extrapolation of Adult Efficacy to Pediatric Patients With Chemotherapy-Induced Nausea and VomitingJeremiah D Momper, M Tobias Heinrichs, Kevin Krudys, et al.
Journal of Pediatric Gastroenterology and Nutrition|November 23, 2016
Esomeprazole FDA Approval in Children With GERD: Exposure-Matching and Exposure-ResponseJustin C Earp, Nitin Mehrotra, Kristina E Peters, et al.
American Heart Journal|June 22, 2015
Considerations for assessing the potential effects of antidiabetes drugs on cardiac ventricular repolarization: A report from the Cardiac Safety Research ConsortiumSimon Heller, Börje Darpö, Malcolm I Mitchell, et al.
Clinical Pharmacokinetics|September 8, 2011
Impact of pharmacometric analyses on new drug approval and labelling decisions: a review of 198 submissions between 2000 and 2008Joo Yeon Lee, Christine E Garnett, Jogarao V S Gobburu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 22, 2013
Enzalutamide for treatment of patients with metastatic castration-resistant prostate cancer who have previously received docetaxel: U.S. Food and Drug Administration drug approval summaryYangmin M Ning, William Pierce, V Ellen Maher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2014
U.S. Food and drug administration approval: obinutuzumab in combination with chlorambucil for the treatment of previously untreated chronic lymphocytic leukemiaHyon-Zu Lee, Barry W Miller, Virginia E Kwitkowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2015
FDA Approval: BlinatumomabDonna Przepiorka, Chia-Wen Ko, Albert Deisseroth, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Clinical Pharmacokinetics|May 27, 2026
Vutrisiran-Mediated Knockdown of Transthyretin in Patients with ATTR AmyloidosisMarianna Fontana, Vincent Algalarrondo, Pablo Garcia-Pavia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2015
FDA approval: siltuximab for the treatment of patients with multicentric Castleman diseaseAlbert Deisseroth, Chia-Wen Ko, Lei Nie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 24, 2013
Abiraterone acetate in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer: U.S. Food and Drug Administration drug approval summaryPaul G Kluetz, Yang-Min Ning, V Ellen Maher, et al.
Journal of Clinical Pharmacology|January 23, 2020
Extrapolation of Adult Efficacy to Pediatric Patients With Chemotherapy-Induced Nausea and VomitingJeremiah D Momper, M Tobias Heinrichs, Kevin Krudys, et al.
Journal of Pediatric Gastroenterology and Nutrition|November 23, 2016
Esomeprazole FDA Approval in Children With GERD: Exposure-Matching and Exposure-ResponseJustin C Earp, Nitin Mehrotra, Kristina E Peters, et al.
American Heart Journal|June 22, 2015
Considerations for assessing the potential effects of antidiabetes drugs on cardiac ventricular repolarization: A report from the Cardiac Safety Research ConsortiumSimon Heller, Börje Darpö, Malcolm I Mitchell, et al.
Clinical Pharmacokinetics|September 8, 2011
Impact of pharmacometric analyses on new drug approval and labelling decisions: a review of 198 submissions between 2000 and 2008Joo Yeon Lee, Christine E Garnett, Jogarao V S Gobburu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 22, 2013
Enzalutamide for treatment of patients with metastatic castration-resistant prostate cancer who have previously received docetaxel: U.S. Food and Drug Administration drug approval summaryYangmin M Ning, William Pierce, V Ellen Maher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2014
U.S. Food and drug administration approval: obinutuzumab in combination with chlorambucil for the treatment of previously untreated chronic lymphocytic leukemiaHyon-Zu Lee, Barry W Miller, Virginia E Kwitkowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2015
FDA Approval: BlinatumomabDonna Przepiorka, Chia-Wen Ko, Albert Deisseroth, et al.
Pageof 5